Motif Bio plc Signs Agreement with Otto-Von-Guericke University Magdeburg to Conduct Study Evaluating Iclaprim in Vitro Model of Ocular Toxoplasmosis
May 22, 2019 at 11:30 am IST
Motif Bio plc announced that the Company has signed an agreement with Otto-von-Guericke University Magdeburg to conduct a study evaluating iclaprim in vitro model of ocular toxoplasmosis. The research will focus on toxoplasma chorioretinitis, an orphan disease that is a type of ocular toxoplasmosis, a parasitic disease that may result in severe life-threatening infections and/or blindness. The work will be led by Prof. Dr. Ildiko Rita Dunay, Director, Institute of Inflammation and Neurodegeneration at the university.